Suppr超能文献

猪IgG1 Fc的表面展示通过促进病毒补体逃逸和哺乳动物细胞转导提高杆状病毒载体疫苗的效力。

Surface displaying of swine IgG1 Fc enhances baculovirus-vectored vaccine efficacy by facilitating viral complement escape and mammalian cell transduction.

作者信息

Liu Zehui, Liu Yangkun, Zhang Yuanyuan, Yang Yajuan, Ren Jingjing, Zhang Xiaoying, Du Enqi

机构信息

College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China.

出版信息

Vet Res. 2017 May 12;48(1):29. doi: 10.1186/s13567-017-0434-5.

Abstract

Baculovirus-mediated gene transfer has been developed as a vaccine design strategy against a number of diseases without apparent viral replication. However, it has been hampered by complement-dependent inactivation, thus hindering the in vivo application of baculovirus. A variety of approaches have been exploited to bypass the complement system in the serum. In this study, we constructed and screened a series of baculovirus vectors displaying complement interfering factors, of which a baculovirus vector displaying swine IgG1 Fc (pFc) showed the highest complement antagonism (75.6%). Flow cytometry analysis of transduced cells demonstrated that the baculovirus display of pFc had a significant increase in transduction efficiency and transgene expression of reporter genes. On this basis, a VSV-G-pseudotyped with swine IgG1 Fc surface displayed baculovirus vector was developed to express the classical swine fever virus (CSFV) E2 gene. The translational enhancers Syn21 and P10UTR were incorporated to improve the antigen expression. The E2 gene was efficiently expressed in both insect and mammalian cells. Pigs immunized with this recombinant baculovirus developed high levels of E2-specific antibody, CSFV-specific neutralizing antibody and IFN-γ-secreting cellular immune responses. These results demonstrate that the strategy of surface-displaying swine IgG1 Fc has a great potential to improve the efficiency of baculovirus-vectored vaccine for CSFV and other swine pathogens.

摘要

杆状病毒介导的基因转移已被开发为一种针对多种疾病的疫苗设计策略,且无明显病毒复制。然而,它受到补体依赖性失活的阻碍,从而妨碍了杆状病毒在体内的应用。人们已采用多种方法来绕过血清中的补体系统。在本研究中,我们构建并筛选了一系列展示补体干扰因子的杆状病毒载体,其中展示猪IgG1 Fc的杆状病毒载体(pFc)表现出最高的补体拮抗作用(75.6%)。对转导细胞的流式细胞术分析表明,pFc的杆状病毒展示使报告基因的转导效率和转基因表达显著增加。在此基础上,开发了一种表面展示猪IgG1 Fc的VSV-G假型化杆状病毒载体,以表达经典猪瘟病毒(CSFV)E2基因。引入翻译增强子Syn21和P10UTR以提高抗原表达。E2基因在昆虫和哺乳动物细胞中均能有效表达。用这种重组杆状病毒免疫的猪产生了高水平的E2特异性抗体、CSFV特异性中和抗体和分泌IFN-γ的细胞免疫反应。这些结果表明,表面展示猪IgG1 Fc的策略在提高杆状病毒载体疫苗针对CSFV和其他猪病原体的效率方面具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/701ba809faa9/13567_2017_434_Fig1_HTML.jpg

相似文献

3
A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.
Vaccine. 2011 Oct 26;29(46):8364-72. doi: 10.1016/j.vaccine.2011.08.085. Epub 2011 Sep 5.
5
Immune responses induced by a BacMam virus expressing the E2 protein of classical swine fever virus in mice.
Immunol Lett. 2009 Aug 15;125(2):145-50. doi: 10.1016/j.imlet.2009.07.001. Epub 2009 Jul 7.
6
Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
Vaccine. 2007 Aug 1;25(31):5915-26. doi: 10.1016/j.vaccine.2007.05.035. Epub 2007 Jun 8.
7
Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus.
Res Vet Sci. 2010 Feb;88(1):77-82. doi: 10.1016/j.rvsc.2009.06.005. Epub 2009 Jul 7.
8
Baculovirus surface display of E(rns) envelope glycoprotein of classical swine fever virus.
J Virol Methods. 2008 Nov;153(2):149-55. doi: 10.1016/j.jviromet.2008.07.019. Epub 2008 Sep 5.
10

本文引用的文献

2
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits.
Vaccine. 2016 Jan 20;34(4):413-423. doi: 10.1016/j.vaccine.2015.11.062. Epub 2015 Dec 13.
3
Enhanced production of porcine circovirus type 2 (PCV2) virus-like particles in Sf9 cells by translational enhancers.
Biotechnol Lett. 2015 Sep;37(9):1765-71. doi: 10.1007/s10529-015-1856-7. Epub 2015 May 21.
4
The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors.
Biotechnol J. 2015 May;10(5):702-14. doi: 10.1002/biot.201400438. Epub 2015 Mar 20.
5
Studying classical swine fever virus: making the best of a bad virus.
Virus Res. 2015 Feb 2;197:35-47. doi: 10.1016/j.virusres.2014.12.006. Epub 2014 Dec 12.
6
Fc fusion as a platform technology: potential for modulating immunogenicity.
Trends Biotechnol. 2015 Jan;33(1):27-34. doi: 10.1016/j.tibtech.2014.11.001. Epub 2014 Dec 6.
7
Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo.
J Virol. 2013 May;87(9):4965-73. doi: 10.1128/JVI.03510-12. Epub 2013 Feb 13.
9
Fc-fusion proteins: new developments and future perspectives.
EMBO Mol Med. 2012 Oct;4(10):1015-28. doi: 10.1002/emmm.201201379. Epub 2012 Jul 26.
10
Polymeric human Fc-fusion proteins with modified effector functions.
Sci Rep. 2011;1:124. doi: 10.1038/srep00124. Epub 2011 Oct 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验